Literature DB >> 33432319

Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonance.

Alexios S Antonopoulos1, Alessia Azzu1,2, Emmanuel Androulakis1, Chonthicha Tanking1, Panagiotis Papagkikas1, Raad H Mohiaddin1,2.   

Abstract

AIMS : Eosinophilic heart disease (EHD) is a rare cardiac condition with a wide spectrum of phenotypes. The diagnostic and prognostic value of cardiac magnetic resonance (CMR) in EHD remains unknown. METHODS AND RESULTS : This was a retrospective analysis of 250 patients with eosinophilia referred for a CMR scan (period 2000-2020). CMR data sets and clinical/laboratory data were collected. Patients were followed up for a mean of 24 months (range 1-224) for the composite endpoint of death, acute coronary syndrome, hospitalization for acute heart failure, malignant ventricular arrhythmias, or the need for implantable cardiac defibrillator/pacemaker. The main objectives were to explore the diagnostic value of CMR in EHD; relationships between cardiac function, late gadolinium enhancement (LGE), and EHD phenotypes; and the prognostic value of fibrosis and oedema by CMR. The prevalence of findings compatible with EHD was 39% (patients with cardiac symptoms: 57% vs. screening: 20%, P < 0.001). EHD phenotypes included subendocardial LGE (n = 58), mid-wall/subepicardial LGE (n = 26), pericarditis (n = 5) or dilated cardiomyopathy (n = 8). Myocardial oedema was present in 10% of patients. Intracardiac thrombi (7%) were associated with EHD phenotype (χ2=47.3, P = 1.3×10-8). LGE extent correlated with LVEDVi (rho = 0.268, P = 5.3×10-5) and LVEF (rho=-0.415, P = 8.6×10-11). A CMR scan positive for EHD [hazard ratio (HR) = 5.61, 95% confidence interval (CI): 1.82-17.89, P = 0.0026] or a subendocardial LGE pattern (HR = 5.13, 95% CI: 1.29-20.38, P = 0.020) were independently associated with the composite clinical endpoint. CONCLUSION : The diagnostic yield of CMR screening in patients with persistent eosinophilia, even if asymptomatic, is high. The extent of subendocardial fibrosis correlates with LV remodelling and independently predicts clinical outcomes in patients with eosinophilia. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiac magnetic resonance; diagnosis; eosinophilia; fibrosis; late gadolinium enhancement; prognosis

Year:  2021        PMID: 33432319     DOI: 10.1093/ehjci/jeaa346

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  2 in total

1.  Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes.

Authors:  Alexios S Antonopoulos; Maria Boutsikou; Spyridon Simantiris; Andreas Angelopoulos; George Lazaros; Ioannis Panagiotopoulos; Evangelos Oikonomou; Mikela Kanoupaki; Dimitris Tousoulis; Raad H Mohiaddin; Konstantinos Tsioufis; Charalambos Vlachopoulos
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

2.  Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in Neuromuscular Cardiomyopathies.

Authors:  Batool Almogheer; Alexios S Antonopoulos; Alessia Azzu; Safaa Al Mohdar; Charalambos Vlachopoulos; Antonios Pantazis; Raad H Mohiaddin
Journal:  Pediatr Cardiol       Date:  2021-08-03       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.